|
Volumn 104, Issue 12, 2009, Pages 3024-3026
|
Editorial: Colorectal cancer and statins: Reflections from the end of the road
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CANCER PREVENTION;
CANCER RISK;
CLINICAL TRIAL;
COHORT ANALYSIS;
COLORECTAL CANCER;
DRUG EFFECT;
HUMAN;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
UNITED STATES;
AGED;
COHORT STUDIES;
COLORECTAL NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INCIDENCE;
MALE;
MANITOBA;
MIDDLE AGED;
REGISTRIES;
RESEARCH DESIGN;
SOCIAL CLASS;
|
EID: 72949121694
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2009.572 Document Type: Review |
Times cited : (5)
|
References (9)
|